Back to BlackRock, Inc. BlackRock, Inc.

IBRXIBRX
6 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in IMMUNITYBIO INC

BlackRock, Inc. holds 26.3M shares of IBRX (IMMUNITYBIO INC), worth $202.1M as of 2026-Q1. The position was increased (+2.9% shares). IBRX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$202.1M

Current Shares

26.3M

Total Value Change

+$167.3M

Total Shares Change

+12.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
26.3M
+2.9%
$202.1M0.0%$10.00
31
2025-Q4
Increased
25.6M
+29.2%
$50.7M0.0%$1.98
37
2025-Q3
Increased
19.8M
+11.5%
$48.7M0.0%$2.57
33
2025-Q2
Increased
17.8M
+33.7%
$46.9M0.0%$2.70
38
2025-Q1
Decreased
13.3M
-2.2%
$40M0.0%$3.14
0
2024-Q4
New
13.6M
-
$34.8M0.0%$2.68
40

Other major holders of IBRX: STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, D. E. Shaw & Co., Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used